Skip to main content

Charles River Laboratories International, Inc. (CRL)

Sector
Health Care
Industry
Life Sciences Tools & Services
Last price
$335.52
As of

Kresmion compiles this page from CRL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.

As of . Source: SEC EDGAR filings for CRL. Method and limitations.

COMPANY DOSSIER

See the full CRL dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for CRL on one page. Preview it with sample data, then open it live with a free account.

Preview the CRL dossier

Active events for CRL

FREE, NO ACCOUNT

Every event on CRL, as it fires

You are seeing 5 of 8 events recorded on CRL since 2026-05-26.

The five above landed across 2 days. The other 3 were recorded on 2 other days. 5 of the 8 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, CRL

More data on CRL

CRL against its peers

CRL's operating margin of 0.6% ranks in the 52nd percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.

MetricCRLPeer medianPercentilen
Revenue FY4.0B USD1.2B USD7125
Gross marginn/a59.1%n/a17
Operating margin0.6%-3.8%5223
Net margin-3.6%-0.3%4825
Return on equity-4.6%-2.9%5024
P / En/a42.4xn/a11
1 year106.2%22.5%8325

Peers (25): MEDP, TEM, TECH, RGEN, AVTR, BRKR, ILMN, TXG, MTD, IQV, A, SHC, ADPT, ABCL, WAT, FTRE, DHR, MRVI, TMO, MLAB, CTKB, OABI, DNA, PACB, CDXS. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CRL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in CRL on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CRL in the last 180 days.

Upstream: SEC EDGAR filings for CRL

Kresmion, "CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) institutional holdings and SEC filings", data as of 2026-11-09, https://kresmion.com/research/CRL. Upstream data: SEC EDGAR filings for CRL.

Link to this data (HTML):

<a href="https://kresmion.com/research/CRL">CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow CRL on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CRL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the CRL dossier
Share

The CRL intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.